Inventor
SISTLA RAMESH KUMAR
IN21 patents
Patents
21 patentsUS9790169B2Oct 17, 2017
IDO inhibitors
BRISTOL MYERS SQUIBB CO19 citations91
US10071079B2Sep 11, 2018
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations84
US10912766B2Feb 9, 2021
[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations83
US12286428B2Apr 29, 2025
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO2 citations74
USRE49880EMar 26, 2024
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO2 citations73
US10959986B2Mar 30, 2021
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO3 citations72
US10660877B2May 26, 2020
Pyridyl substituted indole compounds
BRISTOL MYERS SQUIBB CO6 citations72
USRE49893EApr 2, 2024
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO1 citations71
US10399932B2Sep 3, 2019
Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer
BRISTOL MYERS SQUIBB CO3 citations71
US10202390B2Feb 12, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019
IDO inhibitors
BRISTOL MYERS SQUIBB CO1 citations71
US11672780B2Jun 13, 2023
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
BRISTOL MYERS SQUIBB CO0 citations62
US10544120B2Jan 28, 2020
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US10246469B2Apr 2, 2019
Biaryl kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US10544133B2Jan 28, 2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations52
US12059420B2Aug 13, 2024
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
BRISTOL MYERS SQUIBB CO0 citations51
US11739098B2Aug 29, 2023
Substituted indole compounds
BRISTOL MYERS SQUIBB CO0 citations51
US10227340B2Mar 12, 2019
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US12473304B2Nov 18, 2025
Heterocyclic PAD4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations43
US10618903B2Apr 14, 2020
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO0 citations39
US10730863B2Aug 4, 2020
Bridged bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations38